About Donald Manning, M.D., Ph.D
Form D filings for Axonis Therapeutics in 2024 list Donald Manning, M.D., Ph.D as r.
Donald Manning, M.D., Ph.D first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Donald Manning, M.D., Ph.D in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Donald Manning, M.D., Ph.D works with at each company, as listed on that company's latest Form D.
Axonis Therapeutics, Inc. · Form D, Nov 1, 2024
JI
Jeffrey Imbaro
Chief Operating Officer
CG
Corey Goodman
Director
BR
Brock Reeve
Director
SH
Shane Hegarty
Executive officer
JS
Joanna Stanicka
Executive officer and director
JL
Jonathan Leff
Director
RK
Raymond Kelleher
Director